Cold Agglutinin Disease

Search Trials
Safety, Tolerability and Activity of BIVV009 in Healthy Volunteers and Patients With Complement Mediated Disorders
Status:
Recruiting
Last Changed:
Jan 1, 1970
First Changed:
Jan 1, 1970
Disease(s):
Bullous Pemphigoid (BP)
Intervention(s):
BIV009Placebo
The RITAI Cohort: An Observational Study on Rituximab Off-label Use for Auto-immune Disorders
Status:
Completed
Last Changed:
Jan 1, 1970
First Changed:
Jan 1, 1970
Disease(s):
Pemphigus
Intervention(s):
Rituximab (MABTHERA® or RITUXAN®).
Safety, Tolerability and Activity of TNT009 in Healthy Volunteers and Patients With Complement Mediated Disorders
Status:
Recruiting
Last Changed:
Jan 1, 1970
First Changed:
Jan 1, 1970
Disease(s):
Bullous Pemphigoid (BP)
Intervention(s):
TNT009Placebo
A Study to Assess the Efficacy and Safety of BIVV009 (Sutimlimab) in Participants With Primary Cold Agglutinin Disease Without A Recent History of Blood Transfusion (Cadenza Study)
Status:
Recruiting
Last Changed:
Jan 1, 1970
First Changed:
Jan 1, 1970
Disease(s):
Agglutinin Disease, Cold
Intervention(s):
SutimlimabPlacebo
A Study to Assess the Efficacy and Safety of BIVV009 (Sutimlimab) in Participants With Primary Cold Agglutinin Disease Who Have a Recent History of Blood Transfusion (Cardinal Study)
Status:
Active, not recruiting
Last Changed:
Jul 1, 2019
First Changed:
Jan 1, 1970
Disease(s):
Agglutinin Disease, Cold
Intervention(s):
Sutimlimab

Connect. Empower. Inspire.